Stay updated on Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Sign up to get notified when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.

Latest updates to the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. This is a minor maintenance change and does not affect the study details or page behavior.SummaryDifference0.1%

- Check20 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. This appears to be a metadata/maintenance update with no changes to study content.SummaryDifference0.1%

- Check27 days agoChange DetectedIntroduced a 'Show glossary' control and updated metadata text, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0' tag.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the prior Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page reorganizes location information under a new top-level 'Locations' section listing CA, FL, KS, MN, NE, NC, OH, and TX, removing the prior per-state subsections; the overall geographic coverage remains the same.SummaryDifference1%

- Check92 days agoChange DetectedAdded a new revision label 'Revision: v3.3.2'. Removed the previous revision label 'Revision: v3.2.0'.SummaryDifference0.1%

Stay in the know with updates to Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.